BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36345568)

  • 1. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Screening Uptake in Transgender Women.
    Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
    JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.
    Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
    NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.
    Gu J; Chery L; González GMN; Huff C; Strom S; Jones JA; Griffith DP; Canfield SE; Wang X; Huang X; Roberson P; Meng QH; Troncoso P; Ittmann M; Covinsky M; Scheurer M; Irizarry Ramirez M; Pettaway CA
    Prostate; 2024 May; 84(7):694-705. PubMed ID: 38477020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California.
    Press DJ; Shariff-Marco S; Lichtensztajn DY; Lauderdale D; Murphy AB; Inamdar PP; DeRouen MC; Hamilton AS; Yang J; Lin K; Hedeker D; Haiman CA; Cheng I; Gomez SL
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):404-412. PubMed ID: 34853020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
    Qian Z; Chen X; Cole AP; Abdollah F; Choueiri TK; Kibel AS; Lipsitz SR; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Feb; 7(1):151-154. PubMed ID: 37487814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance System.
    Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Peipins LA; Smith JL
    J Am Board Fam Med; 2021; 34(3):634-647. PubMed ID: 34088823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.
    Morley F; Iyer HS; Tamimi RM; Nanus DM; Rebbeck TR; Kensler KH
    Cancer Causes Control; 2024 Mar; 35(3):509-521. PubMed ID: 37878135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality.
    Stone BV; Labban M; Beatrici E; Filipas DK; D'Amico AV; Lipsitz SR; Choueiri TK; Kibel AS; Cole AP; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Jun; 7(3):563-569. PubMed ID: 38155059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision Making.
    Frego N; Beatrici E; Labban M; Stone BV; Filipas DK; Koelker M; Lughezzani G; Buffi NM; Osman NY; Lipsitz SR; Sammon JD; Kibel AS; Trinh QD; Cole AP
    Am J Prev Med; 2024 Jan; 66(1):27-36. PubMed ID: 37567369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do African-American men need separate prostate cancer screening guidelines?
    Shenoy D; Packianathan S; Chen AM; Vijayakumar S
    BMC Urol; 2016 May; 16(1):19. PubMed ID: 27165293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men.
    Lee KM; Bryant AK; Lynch JA; Robison B; Alba PR; Agiri FY; Pridgen KM; DuVall SL; Yamoah K; Garraway IP; Rose BS
    Cancer; 2024 Jan; 130(2):224-231. PubMed ID: 37927109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.
    Frendl DM; Epstein MM; Fouayzi H; Krajenta R; Rybicki BA; Sokoloff MH
    Cancer Causes Control; 2020 Sep; 31(9):861-867. PubMed ID: 32556947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African american primary care physicians' prostate cancer screening practices.
    Ross LE; Hall IJ
    J Prim Care Community Health; 2014 Jan; 5(1):36-43. PubMed ID: 24327595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening in African American men: a review of the evidence.
    Kensler KH; Johnson R; Morley F; Albrair M; Dickerman BA; Gulati R; Holt SK; Iyer HS; Kibel AS; Lee JR; Preston MA; Vassy JL; Wolff EM; Nyame YA; Etzioni R; Rebbeck TR
    J Natl Cancer Inst; 2024 Jan; 116(1):34-52. PubMed ID: 37713266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talking About Your Prostate: Perspectives from Providers and Community Members.
    Choi SK; Seel JS; Steck SE; Payne J; McCormick D; Schrock CS; Friedman DB
    J Cancer Educ; 2018 Oct; 33(5):1052-1060. PubMed ID: 28271389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men.
    Watson K; Buscemi J; Fitzgibbon M; Murray M; Murphy A; Abern M; Gann P; Levi JB; Stinson J; Diefenbach M; Winn RA
    Transl Behav Med; 2020 May; 10(2):492-494. PubMed ID: 30855080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.